The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Evolv Technologies Holdings, Inc. | COM CL A | 30049H102 | 47,051,023 | 9,681,280 | SH | SOLE | 9,681,280 | 0 | 0 | |||
| Mind Medicine (MindMed) Inc. | COM NEW | 60255C885 | 314,095 | 100,349 | SH | SOLE | 100,349 | 0 | 0 | |||
| Recursion Pharmaceuticals, Inc. | CL A | 75629V104 | 45,449,568 | 5,941,120 | SH | SOLE | 5,941,120 | 0 | 0 | |||
| Rocket Lab USA, Inc. | COM | 773122106 | 12,830,553 | 2,929,350 | SH | SOLE | 2,929,350 | 0 | 0 | |||
| Roivant Sciences Ltd. | SHS | G76279101 | 45,260 | 3,875 | SH | SOLE | 3,875 | 0 | 0 | |||